Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation. Pfizer, whose vaccinee developed with German company BioNTech was the first approved to counter the deadly virus, sees slightly lower … Continue reading Pfizer’s 2021 profits doubled to $22 billion on COVID vaccine sales